Holen Sie sich die Stockscreener-App
106.19
1.55%
1.62
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Finanzdaten der Abbott Laboratories-Aktie (ABT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
2.57%
11,164.00
|
11,459.00 | 11,369.00 | 11,142.00 | 10,358.00 |
| Cost Of Revenue |
0.65%
4,890.00
|
4,922.00 | 5,075.00 | 4,854.00 | 4,468.00 |
Selling, General, and Administrative
|
19.53%
3,740.00
|
3,129.00 | 3,051.00 | - | - |
| Costs And Expenses |
6.64%
9,819.00
|
9,208.00 | 9,312.00 | 9,090.00 | 8,665.00 |
| Operating Income/Loss |
40.25%
1,345.00
|
2,251.00 | 2,057.00 | 2,052.00 | 1,693.00 |
| Income/Loss From Continuing Operations Before Tax |
38.55%
1,449.00
|
2,358.00 | 2,180.00 | 2,150.00 | 1,778.00 |
| Income Tax Expense/Benefit, Current |
372.00
|
- | - | - | 453.00 |
| Income Tax Expense/Benefit |
36.08%
372.00
|
582.00 | 536.00 | 371.00 | 453.00 |
|
Net Income/Loss
|
39.36%
1,077.00
|
1,776.00 | 1,644.00 | 1,779.00 | 1,325.00 |
| Basic Average Shares |
1,742.48
|
- | 1,742.14 | 1,743.44 | 1,739.21 |
| Diluted Average Shares |
1,747.07
|
- | 1,749.36 | 1,750.84 | 1,747.22 |
| Basic Earnings Per Share |
0.62
|
- | 0.94 | 1.02 | 0.76 |
| Diluted Earnings Per Share |
0.61
|
- | 0.94 | 1.01 | 0.76 |
| Common Stock Dividends |
0.00%
0.63
|
0.63 | 0.59 | 0.59 | 0.59 |
0.25%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):